200 related articles for article (PubMed ID: 15373786)
21. Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.
Cutlar L; Greiser U; Wang W
Exp Dermatol; 2014 Jan; 23(1):1-6. PubMed ID: 24107073
[TBL] [Abstract][Full Text] [Related]
22. A recurrent nonsense mutation occurring as a de novo event in a patient with recessive dystrophic epidermolysis bullosa.
Cuadrado-Corrales N; Sánchez-Jimeno C; García M; Ayuso C; De Lucas R; Vicario JL; Conti CJ; Zambruno G; Escamez MJ; Del Rio M
Dermatology; 2011; 223(3):219-21. PubMed ID: 21849769
[No Abstract] [Full Text] [Related]
23. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
[TBL] [Abstract][Full Text] [Related]
24. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
[TBL] [Abstract][Full Text] [Related]
25. Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene.
Hovnanian A; Duquesnoy P; Blanchet-Bardon C; Knowlton RG; Amselem S; Lathrop M; Dubertret L; Uitto J; Goossens M
J Clin Invest; 1992 Sep; 90(3):1032-6. PubMed ID: 1355776
[TBL] [Abstract][Full Text] [Related]
26. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
South AP; O'Toole EA
Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
[TBL] [Abstract][Full Text] [Related]
27. Construction of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa.
Gache Y; Baldeschi C; Del Rio M; Gagnoux-Palacios L; Larcher F; Lacour JP; Meneguzzi G
Hum Gene Ther; 2004 Oct; 15(10):921-33. PubMed ID: 15585108
[TBL] [Abstract][Full Text] [Related]
28. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
[TBL] [Abstract][Full Text] [Related]
29. A 13-year-old girl with recessive dystrophic epidermolysis bullosa presenting with squamous cell carcinoma.
Ayman T; Yerebakan O; Ciftçioglu MA; Alpsoy E
Pediatr Dermatol; 2002; 19(5):436-8. PubMed ID: 12383103
[TBL] [Abstract][Full Text] [Related]
30. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
Otte HG; Stieler W; Anton-Lamprecht I
Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
[TBL] [Abstract][Full Text] [Related]
31. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
32. Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression.
Mittapalli VR; Madl J; Löffek S; Kiritsi D; Kern JS; Römer W; Nyström A; Bruckner-Tuderman L
Cancer Res; 2016 Feb; 76(4):940-51. PubMed ID: 26676755
[TBL] [Abstract][Full Text] [Related]
33. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations.
McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA
J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327
[TBL] [Abstract][Full Text] [Related]
34. Monozygotic twins discordant for recessive dystrophic epidermolysis bullosa phenotype highlight the role of TGF-β signalling in modifying disease severity.
Odorisio T; Di Salvio M; Orecchia A; Di Zenzo G; Piccinni E; Cianfarani F; Travaglione A; Uva P; Bellei B; Conti A; Zambruno G; Castiglia D
Hum Mol Genet; 2014 Aug; 23(15):3907-22. PubMed ID: 24599399
[TBL] [Abstract][Full Text] [Related]
35. Expression of mutant p53 gene in squamous carcinoma arising in patients with recessive dystrophic epidermolysis bullosa.
Slater SD; McGrath JA; Hobbs C; Eady RA; McKee PH
Histopathology; 1992 Mar; 20(3):237-41. PubMed ID: 1563710
[TBL] [Abstract][Full Text] [Related]
36. Compound heterozygosity for a recessive glycine substitution and a splice site mutation in the COL7A1 gene causes an unusually mild form of localized recessive dystrophic epidermolysis bullosa.
Terracina M; Posteraro P; Schubert M; Sonego G; Atzori F; Zambruno G; Bruckner-Tuderman L; Castiglia D
J Invest Dermatol; 1998 Nov; 111(5):744-50. PubMed ID: 9804332
[TBL] [Abstract][Full Text] [Related]
37. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
[TBL] [Abstract][Full Text] [Related]
38. p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
Brown VL; Harwood CA; Crook T; Cronin JG; Kelsell DP; Proby CM
J Invest Dermatol; 2004 May; 122(5):1284-92. PubMed ID: 15140233
[TBL] [Abstract][Full Text] [Related]
39. Squamous cell carcinoma in a family with dominant dystrophic epidermolysis bullosa: a molecular genetic study.
Christiano AM; Crollick J; Pincus S; Uitto J
Exp Dermatol; 1999 Apr; 8(2):146-52. PubMed ID: 10232408
[TBL] [Abstract][Full Text] [Related]
40. Three homozygous PTC mutations in the collagen type VII gene of patients affected by recessive dystrophic epidermolysis bullosa: analysis of transcript levels in dermal fibroblasts.
Gardella R; Zoppi N; Ferraboli S; Marini D; Tadini G; Barlati S; Colombi M
Hum Mutat; 1999; 13(6):439-52. PubMed ID: 10408773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
